# Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia

Study · id `cardio:ct-nct01102413` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01102413](<https://clinicaltrials.gov/study/NCT01102413>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01102413

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 351 participants.

## Technical summary

Registry record NCT01102413. Randomized; no masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-06 (actual). Results posted on 2015-12-03.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 351 participants (enrolled count; ClinicalTrials.gov record NCT01102413, source copy `cardio:ctgov-nct01102413-2015-12-03`, retrieved 2026-10-26)
- Start date: 2010-04 (registry gives no type) (ClinicalTrials.gov record NCT01102413, source copy `cardio:ctgov-nct01102413-2015-12-03`, retrieved 2026-10-26)
- Primary completion: 2014-06 (actual) (ClinicalTrials.gov record NCT01102413, source copy `cardio:ctgov-nct01102413-2015-12-03`, retrieved 2026-10-26)
- Completion: 2014-06 (actual) (ClinicalTrials.gov record NCT01102413, source copy `cardio:ctgov-nct01102413-2015-12-03`, retrieved 2026-10-26)
- Results first posted: 2015-12-03 (ClinicalTrials.gov record NCT01102413, source copy `cardio:ctgov-nct01102413-2015-12-03`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT01102413, source copy `cardio:ctgov-nct01102413-2015-12-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01102413-2015-12-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
- Condition: Iron Deficiency Anemia
- Condition: Chronic Kidney Disease
- Intervention (Drug): Monofer
- Intervention (Drug): Iron Sulphate
- Lead sponsor: Pharmacosmos A/S
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Pharmacosmos A/S (`cardio:org-pharmacosmos-a-s`)

## Provenance

Content hash: 774b277328cc60a176c184946c676fa3de0e8fd7fff92814c1fbad0358f201aa
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
